期刊文献+

首发社交恐怖患者血清催产素水平与临床特征的相关性研究 被引量:5

A study on the oxytocin levels and the relationship of symptoms severity with clinical symptoms
原文传递
导出
摘要 目的探讨社交恐怖障碍患者与正常对照组血浆催产素水平差异以及社交恐怖障碍患者血浆催产素水平与症状严重程度、药物疗效的关系。方法16-26岁社交恐怖障碍患者27人,正常对照31人分别接受血浆催产素水平测定,病例组评定社交焦虑量表(Liebowitz Social Anxiety Scale,LSAS)评定症状严重程度,并给予帕罗西汀20mg/d治疗,治疗第4周评定临床疗效总评量表(Clinical Global Impression Seale,CGI)观察药物疗效。结果非参数检验显示社交恐怖障碍患者血浆催产素水平高于正常对照组[(202.93±145.06)pg/ml,(152.29±101.89)pg/m1],差异具有统计学意义(Z=-1.307,P=0.030)。多元线性回归分析显示在社交恐怖障碍患者中,催产素水平是影响社交恐怖障碍严重程度的因素(校正R^2=0.158,F=5.888,P=0.023),非条件logistic回归分析显示基线催产素水平是影响帕罗西汀治疗社交恐怖障碍疗效的因素(OR=3.132,P=0.029)。结论社交恐怖患者存在血浆催产素水平异常,血浆催产素水平可能是社交恐怖障碍严萤稗序以及药物疗效的影响冈索。 Objective To explore the difference of the oxytocin levels between social phobia patients and normal controls, and the relationship of symptoms severity of social phobia with the oxytocin levels and the relationship of drug effects with oxytoein levels. Methods Twenty seven 16-26 years old social phobia patients and thirty one normal controls were tested by an enzymelinked immunosorbent assay to evaluate the oxytocin levels, and the Liebowitz Social Anxiety Scale was used to evaluate the symptoms severity of social phobia in patient group. Paroxetine was used to treat the patients with the drugs of 20mg per day,the Clinical Global Impression Scale were used to evaluate the drug effects after 4 weeks treatment. Results Mann-Whitney test showed there were significantly differences in oxytocin level between patients and controls ( (202.93±145.06) pg/ml vs ( 152.29 ±101.89 ) pg/ml,Z = - 1. 307, P = 0. 030). Multiple liner regression analyses showed that the level of oxytocin was an impact factor of the severity of social phobia symptom ( adjusted R: = 0. 158, F= 5. 888, P= 0. 023 ). Logistic regression analyses showed that the level of oxytocin was an impact factor of the effective of drug treatment ( OR = 3. 132, P = 0.029 ). Conclusion This study indicate that the value of plasma oxytoein maybe significantly differences between social phobia and normal controls and the plasma oxytoein level maybe a factor which influence the symptoms severity and the effective of drug treatment in social phobia patients.
出处 《中华行为医学与脑科学杂志》 CAS CSCD 北大核心 2012年第3期244-246,共3页 Chinese Journal of Behavioral Medicine and Brain Science
关键词 社交恐怖障碍 血浆催产素水平 帕罗西汀 Social phobia Oxytocin level Paroxetine
  • 相关文献

参考文献14

  • 1杜启峰,李舍予,董再全,邱昌建,刘可智,孟雅靖,张伟.成都市小学生社交焦虑障碍患病率及影响因素[J].中华行为医学与脑科学杂志,2010,19(11):964-966. 被引量:6
  • 2康颖,静进.孤独症的病因分子机制与遗传生物学研究进展[J].中华行为医学与脑科学杂志,2010,19(10):953-955. 被引量:14
  • 3刘金婷,蔡强,王若菡,吴寅.催产素与人类社会行为[J].心理科学进展,2011,19(10):1480-1492. 被引量:34
  • 4Hoge EA, Pollack MH, Kaufman RE, et al. Oxytocin levels in social anxiety disorder. CNS Neurosci Ther,2008,14 : 165-170.
  • 5Stein M, Liebowitz MR, Lydiard RB, et al. Paroxetine treatment of generalized social phobia ( social anxiety disorder) : a randomized controlled trial. JAMA,1998 ,280 :708-713.
  • 6American Psychiatry Association. Diagnostic and statistical manual of mental disorders. 4thed. American Psychiatry Association, 1994.
  • 7Kostoglou Athanassiou I,Athanassiou P,Treacher DF,et al. Neurohypophysial hormone and melatonin secretion over the natural and suppressed menstrual cycle in premenopausal women. Clin Endocrinol, 1998,49:209-216.
  • 8潘集阳,张继辉,马萍,梁华君,王厚亮,陶炯,温盛林,张晋碚.Liebowitz社交焦虑量表在社交焦虑障碍评定中的应用(英文)[J].中国神经精神疾病杂志,2006,32(3):206-210. 被引量:7
  • 9Di Simplicio M,Massey Chase R, Cowen PJ, et al. Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers. J Psychopharmacol,2009,23 : 241-248.
  • 10Domes G, Heinrichs M, Michel A, et al. Oxytocin improves " mindreading" in humans. Biol Psychiatry,2007,61:731-733.

二级参考文献102

  • 1肖融,吴薇莉,胡峻梅,邱昌建,王强,魏庚,孙锦华,杨闯,宋萍,叶安红,张伟.成都市大中学生社交焦虑障碍患病率及发病影响因素分析[J].四川大学学报(医学版),2006,37(4):636-640. 被引量:30
  • 2Stein MB,Kean YM.Disability and quality of life in social phobia:epidemiologic findings.Am J Psychiatry,2000,157:1606-1613.
  • 3Faravelli C,Zucchi T,Viviani B,et al.Epidemiology of social phobia:a clinical approach.Eur Psychiatry,2000,15:17-24.
  • 4梁雪梅.成都市区女性大中学生进食障碍患病率及相关社会心理因素研究.成都:四川大学,2007.
  • 5Goodman R,Ford T,Richards H,et al.The development and wellbeing assessment:description and initial validation of an integrated assessment of child and adolescent psychopathology.J Child Psychiatry,2000,41:645-655.
  • 6Wittchen HU,Stein MB,Kessler RC.Social fears and social phobia in a community sample of adolescents and young adults:preyalence,risk factors and co-morbidity.Psychol Med,1999,29:309-323.
  • 7Weeks M,Coplan RJ,Kiugsbury A.The correlates and consequences of early appearing social anxiety in young children.J Anxiety Disord,2009,23:965-972.
  • 8Altemus, M., Jacobson, K. R., Debellis, M., Kling, M., Pigott, T., Murphy, D. L., et al. (1999). Normal CSF oxytocin and NPY levels in OCD. Biological Psychiatry, 45(7), 931-933.
  • 9Andari, E., Duhamel, J. R., Zalla, T., Herbrecht, E., Leboyer, M., & Sirigu, A. (2010). Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proceedings of the National Academy of Sciences of the United States of America, 107(9), 4389-4394.
  • 10Ansseau, M., Legros, L L, Mormont, C., Cerfontaine, L L., Papart, P., Geenen, V., et al. (1987). Intranasal oxytocin in obsessive-compulsive disorder. Psychoneuroendocrinology,12(3),231-236.

共引文献57

同被引文献103

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部